Status:
ACTIVE_NOT_RECRUITING
Objective Grading of MTS With LSCI and Thermography
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Mesenteric Traction Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Mesenteric traction syndrome (MTS) is defined as hypotension, tachycardia and facial flushing in the first hour of surgery, caused by mesenteric traction/abdominal exploration. MTS occurs frequently d...
Eligibility Criteria
Inclusion
- Undergoing curative surgery for esopageal, gastric, doudenal or pancreatic cancer
Exclusion
- Known flushing disease
- Patients recieving NSAID and corticosteroid presurgery, Whipple is allowed to recieve single dose of 125 mg Methylprednisone as part of the standard of care at our facility.
- Palliative surgery
- Surgery not completed due to disseminated disease - patients will still be used in examination of LSCI and Thermography analysis even if desiminated
Key Trial Info
Start Date :
March 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 23 2027
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT04796493
Start Date
March 16 2021
End Date
August 23 2027
Last Update
April 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
København Ø, Capital Region, Denmark, 2100